Home › NDC Lookup › RxCUI directory › RxCUI 2612704

Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti] — RxCUI 2612704

Name: Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti] (RxCUI 2612704)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2612704 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2612704

Official nameOmidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asOMLONTI 0.002 % Ophthalmic Solution; Omlonti 0.02 MG/ML Ophthalmic Solution

FDA products mapped1

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solut... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti] RxCUI 2612704 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Omidenepag 2612691 IN
- Omidenepag isopropyl 2612690 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Omlonti 2612696 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Omidenepag Ophthalmic Solution 2612701 SCDF
- Omidenepag isopropyl Ophthalmic Solution 2645861 SCDFP
- Omidenepag Ophthalmic Product 2612693 SCDG
- Omidenepag isopropyl Ophthalmic Product 2660594 SCDGP
- Omidenepag Ophthalmic Solution [Omlonti] 2612703 SBDF
- Omidenepag isopropyl Ophthalmic Solution [Omlonti] 2654368 SBDFP
- Omlonti Ophthalmic Product 2612698 SBDG
- Ophthalmic Solution 7670 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution 2612702 SCD
- Omidenepag isopropyl 0.02 MG/ML 2612692 SCDC
- Omidenepag isopropyl 0.02 MG/ML [Omlonti] 2612697 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution SCD · 2612702
Omidenepag isopropyl 0.02 MG/ML SCDC · 2612692
Omidenepag Ophthalmic Solution SCDF · 2612701
Omidenepag isopropyl Ophthalmic Solution SCDFP · 2645861
Omidenepag Ophthalmic Product SCDG · 2612693
Omidenepag isopropyl Ophthalmic Product SCDGP · 2660594

Brand-Name Concepts

Omidenepag isopropyl 0.02 MG/ML [Omlonti] SBDC · 2612697
Omidenepag Ophthalmic Solution [Omlonti] SBDF · 2612703
Omidenepag isopropyl Ophthalmic Solution [Omlonti] SBDFP · 2654368
Omlonti Ophthalmic Product SBDG · 2612698
Omlonti BN · 2612696

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 2612704 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
84826-0002-01	1 BOTTLE, PLASTIC in 1 CARTON (84826-002-01) / 2.5 mL in 1...	Omlonti	Ocuvex Therapeutics, Inc.	2025-04-28
84826-0002-03	3 BOTTLE, PLASTIC in 1 CARTON (84826-002-03) / 2.5 mL in 1...	Omlonti	Ocuvex Therapeutics, Inc.	2025-04-28

Observed labelers: Ocuvex Therapeutics, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.